EMEA-002477-PIP01-18

Key facts

Active substance
Human ciliary neurotrophic factor
Therapeutic area
Ophthalmology
Decision number
P/0051/2019
PIP number
EMEA-002477-PIP01-18
Pharmaceutical form(s)
Implant
Condition(s) / indication(s)
Treatment of Macular Telangiectasia Type 2
Route(s) of administration
Intravitreal use
Contact for public enquiries
Neurotech Pharmaceuticals Inc

Tel.  +1 6784272334
E-mail: k.mandell@neurotechusa.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating